Distributional Cost Effectiveness Analysis: A simple example

I have written previously about the need for distributional cost-effectiveness analysis (DCEA) which would increase the value of treatments who improve the health for individuals who currently have the worst expected quality-adjusted life expectancy (QALE). I’ve written about this in AJMC and Health Affairs among other places. One key question many individuals may have is…

Fewer Pharmacies In Minority Neighborhoods

One reason for worse health outcomes for racial minorities could be reduced access to pharmacies. However, how big a problem is pharmacy access? A recent Health Affairs paper by Guadamuz et al. (2021) uses 2007-2015 data from the National Council for Prescription Drug Programs (NCPDP) to identify pharmacies, which were then geocoded and linked to…

COVID-19 and racial disparities

On the eve of Martin Luther King Day, let us take a quick look at the impact of COVID-19 by race/ethnicity. CDC reports rates of COVID-19 cases, hospitalizations and deaths. One can see that cases are higher for most minorities (except Asians) relative to Non-Hispanic Whites, but hospitalizations and deaths are much higher for all…

Disparities in COVID-19 hospitalization rates

Azar et al. (2020) use electronic health record data to examine differences in COVID-19 hospitalization rates by patient characteristics. The authors find that: …compared with non-Hispanic white patients, nonHispanic African American patients had 2.7 times the odds of hospitalization, after adjustment for age, sex, comorbidities, and income. These findings echo similar COVID-19-related conclusions across California.…